List of classifications, Volumes 1–116

Return to list of classifications

List of classifications, Volumes 1-116 (Excel)
List of classifications, Volumes 1-116 (PDF)

Year of publication in print; if published in electronic format only, this is stated as "online"

CAS No.AgentGroupVolumeYearAdditional information
50-00-0Formaldehyde1Sup 7, 62, 88, 100F2012
50-06-6Phenobarbital2BSup 7, 792001
50-07-7Mitomycin C2B10, Sup 71987
50-18-0
6055-19-2
Cyclophosphamide126, Sup 7, 100A2012
50-29-3DDT (4,4'-Dichlorodiphenyltrichloroethane)2ASup 7, 53, 1132016 online
50-32-8Benzo[a]pyrene1Sup 7, 92, 100F2012NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
50-33-9Phenylbutazone313, Sup 71987
50-41-9Clomiphene citrate321, Sup 71987
50-44-26-Mercaptopurine326, Sup 71987
50-55-5Reserpine324, Sup 71987
50-76-0Actinomycin D310, Sup 71987
51-02-5Pronetalol hydrochloride313, Sup 71987
51-03-6Piperonyl butoxide330, Sup 71987
51-18-32,4,6-Tris(1-aziridinyl)-s-triazine39, Sup 71987
51-21-85-Fluorouracil326, Sup 71987
51-52-5Propylthiouracil2BSup 7, 792001
51-75-2Nitrogen mustard2A9, Sup 71987
51-79-6Ethyl carbamate (Urethane)2A7, Sup 7, 962010
52-01-7Spironolactone3Sup 7, 792001
52-24-4Thiotepa1Sup 7, 50, 100A2012
52-46-0Apholate39, Sup 71987
52-68-6Trichlorfon330, Sup 71987
53-03-2Prednisone326, Sup 71987
53-70-3Dibenz[a,h]anthracene2ASup 7, 922010NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
54-05-7Chloroquine313, Sup 71987
54-31-9Furosemide (Frusemide)3501990
54-85-3Isonicotinic acid hydrazide (Isoniazid)34, Sup 71987
55-18-5N-Nitrosodiethylamine2A17, Sup 71987NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
55-98-11,4-Butanediol dimethanesulfonate (see Busulfan)
55-98-1Busulfan14, Sup 7, 100A2012
55-98-1Myleran (see Busulfan)
56-04-2Methylthiouracil2BSup 7, 792001
56-23-5Carbon tetrachloride2B20, Sup 7, 711999
56-25-7Cantharidin310, Sup 71987
56-38-2Parathion2B30, Sup 7, 112In prep.
56-53-1Diethylstilbestrol121, Sup 7, 100A2012
56-55-3Benz[a]anthracene2B92, Sup 72010
56-75-7Chloramphenicol2ASup 7, 501990NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
57-06-7Allyl isothiocyanate373, Sup 71999
57-14-71,1-Dimethylhydrazine2B4, Sup 7, 711999
57-39-6Tris(2-methyl-1-aziridinyl)phosphine oxide39, Sup 71987
57-41-0Phenytoin2BSup 7, 661996
57-57-8beta-Propiolactone2B4, Sup 7, 711999
57-68-1Sulfamethazine3792001NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
57-74-9Chlordane2BSup 7, 53, 792001
57-88-5Cholesterol331, Sup 71987
58-08-2Caffeine3511991
58-14-0Pyrimethamine313, Sup 71987
58-55-9Theophylline3511991
58-89-9Lindane (see also Hexachlorocyclohexanes)1113In prep.
58-93-5Hydrochlorothiazide2B50, 1082016
59-05-2Methotrexate326, Sup 71987
59-87-0Nitrofural (Nitrofurazone)3501990
59-89-2N-Nitrosomorpholine2B17, Sup 71987
60-09-3para-Aminoazobenzene2B8, Sup 71987
60-11-7para-Dimethylaminoazobenzene2B8, Sup 71987
60-35-5Acetamide2B7, Sup 7, 711999
60-56-0Methimazole3792001
60-57-1Dieldrin35, Sup 71987
61-57-4Niridazole2B13, Sup 71987
61-82-5Amitrole379, Sup 72001NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
62-44-2Phenacetin124, Sup 7, 100A2012NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data
62-50-0Ethyl methanesulfonate2B7, Sup 71987
62-53-3Aniline327, Sup 71987
62-55-5Thioacetamide2B7, Sup 71987
62-56-6Thiourea3Sup 7, 792001
62-73-7Dichlorvos2BSup 7, 531991
62-75-9N-Nitrosodimethylamine2A17, Sup 71987NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
63-25-2Carbaryl312, Sup 71987
63-92-3Phenoxybenzamine hydrochloride2B24, Sup 71987
64-17-5Ethanol in alcoholic beverages196, 100E2012
64-67-5Diethyl sulfate2A54, 711999NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
66-27-3Methyl methanesulfonate2A7, Sup 7, 711999NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
66-75-1Uracil mustard2B9, Sup 71987
67-20-9Nitrofurantoin3501990
67-45-8Furazolidone331, Sup 71987
67-63-0Isopropyl alcohol315, Sup 7, 711999
67-66-3Chloroform2BSup 7, 731999
67-72-1Hexachloroethane2B731999
68-12-2Dimethylformamide2A47, 71, 115In prep.
68-76-8Tris(aziridinyl)-para-benzoquinone (Triaziquone)39, Sup 71987
69-53-4Ampicillin3501990
70-25-7N-Methyl-N´-nitro-N-nitrosoguanidine (MNNG)2A4, Sup 71987NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
70-30-4Hexachlorophene320, Sup 71987
71-43-2Benzene129, Sup 7. 100F2012
71-55-61,1,1-Trichloroethane320, Sup 7, 711999
71-58-9Medroxyprogesterone acetate2B21, Sup 71987
72-20-8Endrin35, Sup 71987
72-43-5Methoxychlor320, Sup 71987
72-57-1Trypan blue2B8, Sup 71987
74-83-9Methyl bromide341, Sup 7, 711999
74-85-1Ethylene3Sup 7, 601994
74-87-3Methyl chloride341, Sup 7, 711999
74-88-4Methyl iodide341, Sup 7, 711999
74-96-4Bromoethane352, 711999
75-00-3Chloroethane352, 711999
75-01-4Vinyl chloride1Sup 7, 97, 100F2012
75-02-5Vinyl fluoride2ASup 7, 63, 972008NB: (1) Overall evaluation upgraded to Group 2A based on mechanistic and other relevant data; (2) For practical purposes, vinyl fluoride should be considered to act similarly to the human carcinogen vinyl chloride
75-07-0Acetaldehyde2B36, Sup 7, 711999
75-07-0Acetaldehyde associated with consumption of alcoholic beverages1100E2012
75-09-2Dichloromethane (Methylene chloride)2ASup 7, 71, 110In prep.
75-21-8Ethylene oxide1Sup 7, 60, 97, 100F2012NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
75-25-2Bromoform352, 711999
75-27-4Bromodichloromethane2B52, 711999
75-35-4Vinylidene chloride339, Sup 7, 711999
75-38-7Vinylidene fluoride339, Sup 7, 711999
75-45-6Chlorodifluoromethane341, Sup 7, 711999
75-52-5Nitromethane2B772000
75-55-82-Methylaziridine (Propyleneimine)2B9, Sup 7, 711999
75-56-9Propylene oxide2BSup 7, 601994
75-60-5Dimethylarsinic acid2B100C2012
75-87-6Chloral2A63, 84, 1062014
75-88-72-Chloro-1,1,1-trifluoroethane341, Sup 7, 711999
76-01-7Pentachloroethane341, Sup 7, 711999
76-03-9Trichloroacetic acid2B63, 84, 1062014
76-44-8Heptachlor2BSup 7, 53, 792001
77-09-8Phenolphthalein2B762000
77-78-1Dimethyl sulfate2A4, Sup 7, 711999NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
78-79-5Isoprene2B60, 711999
78-87-51,2-Dichloropropane141, Sup 7, 71, 110In prep.
78-98-8Methylglyoxal3511991
79-00-51,1,2-Trichloroethane352, 711999
79-01-6Trichloroethylene1Sup 7, 63, 1062014
79-06-1Acrylamide2A60, Sup 71994NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
79-10-7Acrylic acid319, Sup 7, 711999
79-34-51,1,2,2-Tetrachloroethane2B20, Sup 7, 71, 1062014
79-43-6Dichloroacetic acid2B63, 84, 1062014
79-44-7Dimethylcarbamoyl chloride2A12, Sup 7, 711999NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
79-46-92-Nitropropane2B29, Sup 7, 711999
79-94-7Tetrabromobisphenol A2A115In prep.
80-08-0Dapsone324, Sup 71987
80-62-6Methyl methacrylate3Sup 7, 601994
81-07-2Saccharin and its salts3Sup 7, 731999NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
81-15-2Musk xylene3651996
81-49-21-Amino-2,4-dibromoanthraquinone2B1012013
81-88-9Rhodamine B316, Sup 71987
82-28-01-Amino-2-methylanthraquinone327, Sup 71987
82-68-8Quintozene (Pentachloronitrobenzene)35, Sup 71987
83-32-9Acenaphthene3922010
83-63-6Diacetylaminoazotoluene38, Sup 71987
83-66-9Musk ambrette3651996
83-67-0Theobromine3511991
84-65-1Anthraquinone2B1012013
85-01-8Phenanthrene3Sup 7, 922010
85-68-7Butyl benzyl phthalate3Sup 7, 731999
85-83-6Scarlet Red38, Sup 71987
85-84-7Yellow AB38, Sup 71987
85-86-9Sudan III38, Sup 71987
86-30-6N-Nitrosodiphenylamine327, Sup 71987
86-54-4Hydralazine324, Sup 71987
86-57-71-Nitronaphthalene3461989
86-73-7Fluorene3Sup 7, 922010
86-74-8Carbazole2B32, Sup 7, 71, 1032013
86-88-41-Naphthylthiourea (ANTU)330, Sup 71987
87-29-6Cinnamyl anthranilate3Sup 7, 772000
87-62-72,6-Dimethylaniline (2,6-Xylidine)2B571993
87-68-3Hexachlorobutadiene3731999
87-86-5Pentachlorophenol (see Polychlorophenols)53, 711999
88-05-12,4,6-Trimethylaniline327, Sup 71987
88-12-0N-Vinyl-2-pyrrolidone319, Sup 7, 711999
88-72-22-Nitrotoluene2A1012013NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
88-73-3
121-73-3
100-00-5
Chloronitrobenzenes3651996
89-82-7Pulegone2B1082016
90-04-0ortho-Anisidine2BSup 7, 731999
90-43-7ortho-Phenylphenol3731999
90-65-3Penicillic acid310, Sup 71987
90-94-8Michler’s ketone [4,4´-Bis(dimethylamino)­benzophenone]2B992010
91-20-3Naphthalene2B822002
91-23-62-Nitroanisole2B651996
91-59-82-Naphthylamine14, Sup 7, 99, 100F2012
91-64-5Coumarin3Sup 7, 772000
91-93-03,3'-Dimethoxybenzidine-4,4'-diisocyanate339, Sup 71987
91-94-13,3'-Dichlorobenzidine2B29, Sup 71987
92-67-14-Aminobiphenyl11, Sup 7, 99, 100F2012
92-87-5Benzidine129, Sup 7, 99, 100F2012
92-93-34-Nitrobiphenyl34, Sup 71987
93-15-2Methyleugenol2B1012013
94-36-0Benzoyl peroxide336, Sup 7, 711999
94-58-6Dihydrosafrole2B10, Sup 71987
94-59-7Safrole2B10, Sup 71987
94-75-72,4-D (2,4-dichlorophenoxyacetic acid) (See also Chlorophenoxy herbicides)2B113In prep.
95-06-7Sulfallate2B30, Sup 71987
95-50-1ortho-Dichlorobenzene3Sup 7, 731999
95-53-4ortho-Toluidine1Sup 7, 77, 99, 100F2012
95-68-12,4-Xylidine316, Sup 71987
95-69-24-Chloro-ortho-toluidine2A77, 992010
95-70-52,5-Diaminotoluene316, Sup 71987
95-78-32,5-Xylidine316, Sup 71987
95-79-45-Chloro-ortho-toluidine377, 992010
95-80-72,4-Diaminotoluene2B16, Sup 71987
95-83-04-Chloro-ortho-phenylenediamine2B27, Sup 71987
96-09-3Styrene-7,8-oxide2ASup 7, 601994NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
96-12-81,2-Dibromo-3-chloropropane2B20, Sup 7, 711999
96-13-92,3-Dibromopropan-1-ol2B772000
96-18-41,2,3-Trichloropropane2A631995
96-23-11,3-Dichloro-2-propanol2B1012013
96-24-23-Monochloro-1,2-propanediol2B1012013
96-33-3Methyl acrylate339, Sup 7, 711999
96-45-7Ethylenethiourea3Sup 7, 792001NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
96-48-0gamma-Butyrolactone311, Sup 7, 711999
97-53-0Eugenol336, Sup 71987
97-56-3ortho-Aminoazotoluene2B8, Sup 71987
97-77-8Disulfiram312, Sup 71987
98-01-1Furfural3631995
98-82-8Cumene2B1012013
98-83-9a-Methylstyrene2B1012013
98-87-3
98-07-7
100-44-7
98-88-4
alpha-Chlorinated toluenes (benzal chloride, benzotrichloride, benzyl chloride) and benzoyl chloride (combined exposures)2A29, Sup 7, 711999
98-95-3Nitrobenzene2B651996
99-08-1
99-99-0
Nitrotoluenes3651996
99-55-85-Nitro-ortho-toluidine3481990
99-56-91,2-Diamino-4-nitrobenzene316, Sup 71987
99-57-02-Amino-4-nitrophenol3571993
99-59-25-Nitro-ortho-anisidine327, Sup 71987
99-80-9N-Methyl-N,4-dinitrosoaniline31, Sup 71987
99-97-8Dimethyl-p-toluidine2B115 In prep.
100-40-34-Vinylcyclohexene2BSup 7, 601994
100-41-4Ethylbenzene2B772000
100-42-5Styrene2B60, 822002
100-75-4N-Nitrosopiperidine2B17, Sup 71987
101-14-44,4'-Methylenebis(2-chloroaniline) (MOCA)1Sup 7, 57, 99, 100F2012NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
101-21-3Chloropropham312, Sup 71987
101-25-7Dinitrosopentamethylenetetramine311, Sup 71987
101-61-1Michler’s base [4,4´-methylenebis(N,N-dimethyl)­benzenamine]2B27, Sup 7, 992010
101-68-84,4'-Methylenediphenyl diisocyanate319, Sup 7, 711999
101-77-94,4'-Methylenedianiline2B39, Sup 71987
101-80-44,4'-Diaminodiphenyl ether2B29, Sup 71987
101-90-6Diglycidyl resorcinol ether2B36, Sup 7, 711999
102-50-1meta-Cresidine327, Sup 71987
102-71-6Triethanolamine3772000
103-03-7Phenicarbazide312, Sup 71987
103-11-72-Ethylhexyl acrylate3601994
103-23-1Di(2-ethylhexyl) adipate3Sup 7, 772000
103-33-3Azobenzene38, Sup 71987
103-90-2Acetaminophen (see Paracetamol)
103-90-2Paracetamol (Acetaminophen)350, 731999
104-94-9para-Anisidine327, Sup 71987
105-11-3para-Benzoquinone dioxime329, Sup 7, 711999
105-55-5N,N'-Diethylthiourea3792001
105-60-2Caprolactam439, Sup 7, 711999
105-74-8Lauroyl peroxide336, Sup 7, 711999
106-46-7para-Dichlorobenzene2BSup 7, 731999
106-47-8para-Chloroaniline2B571993
106-50-3para-Phenylenediamine316, Sup 71987
106-51-4para-Quinone315, Sup 7, 711999
106-87-64-Vinylcyclohexene diepoxide2BSup 7, 601994
106-88-71,2-Epoxybutane2B47, 711999NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
106-89-8Epichlorohydrin2A11, Sup 7, 711999NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
106-93-4Ethylene dibromide2A15, Sup 7, 711999NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
106-94-51-Bromopropane2B115In prep.
106-99-01,3-Butadiene1Sup 7, 54, 71, 97, 100F2012
107-02-8Acrolein363, Sup 71995
107-05-1Allyl chloride336, Sup 7, 711999
107-06-21,2-Dichloroethane2B20, Sup 7, 711999
107-13-1Acrylonitrile2B711999
107-14-2Chloroacetonitrile352, 711999
107-30-2Chloromethyl methyl ether (see Bis(chloromethyl)ether; chloromethyl methyl ether)
108-05-4Vinyl acetate2BSup 7, 631995
108-10-1Methyl isobutyl ketone2B1012013
108-30-5Succinic anhydride315, Sup 71987
108-45-2meta-Phenylenediamine316, Sup 71987
108-46-3Resorcinol315, Sup 7, 711999
108-60-1Bis(2-chloro-1-methylethyl)ether341, Sup 7, 711999
108-78-1Melamine3Sup 7, 731999NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
108-88-3Toluene347, 711999
108-94-1Cyclohexanone347, 711999
108-95-2Phenol347, 711999
110-00-9Furan2B631995
110-57-6trans-1,4-Dichlorobutene315, Sup 7, 711999
110-86-1Pyridine3772000
110-91-8Morpholine347, 711999
111-42-2Diethanolamine2B77, 1012013
111-44-4Bis(2-chloroethyl)ether39, Sup 7, 711999
111-76-22-Butoxyethanol3882006
115-02-6Azaserine2B10, Sup 71987
115-07-1Propylene3Sup 7, 601994
115-28-6Chlorendic acid2B481990
115-32-2Dicofol330, Sup 71987
115-96-8Tris(2-chloroethyl) phosphate348, 711999
116-06-3Aldicarb3531991
116-14-3Tetrafluoroethylene2A19, Sup 7, 71, 110In prep.NB: Overall evaluation upgraded to Group 2A on the basis of sufficient evidence in experimental animals with a striking and atypical pattern of tumours
117-10-2Dantron (Chrysazin; 1,8-Dihydroxyanthraquinone)2B501990
117-39-5Quercetin3Sup 7, 731999
117-79-32-Aminoanthraquinone327, Sup 71987
117-81-7Bis(2-ethylhexyl) phthalate (see Di(2-ethylhexyl) phthalate)
117-81-7Di(2-ethylhexyl)phthalate2BSup 7, 77, 1012013
118-74-1Hexachlorobenzene2BSup 7, 792001
118-92-3Anthranilic acid316, Sup 71987
118-96-72,4,6-Trinitrotoluene3651996
119-34-64-Amino-2-nitrophenol316, Sup 71987
119-61-9Benzophenone2B1012013
119-90-43,3'-Dimethoxybenzidine (ortho-Dianisidine)2B4, Sup 71987
119-93-73,3'-Dimethylbenzidine (ortho-Tolidine)2B1, Sup 71987
120-12-7Anthracene392, Sup 72010
120-58-1Isosafrole310, Sup 71987
120-71-8para-Cresidine2B27, Sup 71987
120-80-9Catechol2B15, Sup 7, 711999
121-14-22,4-Dinitrotoluene2B651996
121-66-42-Amino-5-nitrothiazole331, Sup 71987
121-69-7N,N-Dimethylaniline3571993
121-75-5Malathion2A30, Sup 7, 1122015 online
121-88-02-Amino-5-nitrophenol3571993
122-34-9Simazine353, 731999
122-42-9Propham312, Sup 71987
122-60-1Phenyl glycidyl ether2B47, 711999
123-31-9Hydroquinone315, Sup 7, 711999
123-33-1Maleic hydrazide34, Sup 71987
123-91-11,4-Dioxane2B11, Sup 7, 711999
124-48-1Chlorodibromomethane352, 711999
124-58-3Methylarsonic acid2B100C2012
124-58-3Monomethylarsonic acid (see Methylarsonic acid)2B100C2012
125-33-7Primidone2B1082016
126-07-8Griseofulvin2BSup 7, 792001
126-72-7Tris(2,3-dibromopropyl) phosphate2A20, Sup 7, 711999NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
126-85-2Nitrogen mustard N-oxide2B9, Sup 71987
126-99-8Chloroprene2BSup 7, 711999
127-07-1Hydroxyurea3762000
127-18-4Tetrachloroethylene (Perchloroethylene)2ASup 7, 63, 1062014
127-69-5Sulfafurazole (Sulfisoxazole)324, Sup 71987
128-37-0Butylated hydroxytoluene (BHT)340, Sup 71987
128-66-5Vat Yellow 43481990
129-00-0Pyrene3Sup 7, 922010
129-15-72-Methyl-1-nitroanthraquinone (uncertain purity)2B27, Sup 71987
129-17-9Blue VRS316, Sup 71987
129-20-4Oxyphenbutazone313, Sup 71987
129-43-11-Hydroxyanthraquinone2B822002
131-79-3Yellow OB38, Sup 71987
132-27-4Sodium ortho-phenylphenate2BSup 7, 731999
132-65-0Dibenzothiophene31032013
133-06-2Captan330, Sup 71987
134-32-71-Naphthylamine34, Sup 71987
135-88-6N-Phenyl-2-naphthylamine316, Sup 71987
136-40-3Phenazopyridine hydrochloride2B24, Sup 71987
137-17-72,4,5-Trimethylaniline327, Sup 71987
137-26-8Thiram3Sup 7, 531991
137-30-4Ziram3Sup 7, 531991
138-59-0Shikimic acid340, Sup 71987
139-05-9Cyclamates (sodium cyclamate)3Sup 7, 731999
139-13-9Nitrilotriacetic acid and its salts2B48, 731999NB: Evaluated as a group
139-65-14,4'-Thiodianiline2B27, Sup 71987
139-94-6Nithiazide331, Sup 71987
140-11-4Benzyl acetate340, Sup 7, 711999
140-56-7para-Dimethylaminoazobenzenediazo sodium sulfonate38, Sup 71987
140-57-8Aramite®2B5, Sup 71987
140-88-5Ethyl acrylate2B39, Sup 7, 711999
141-32-2n-Butyl acrylate339, Sup 7, 711999
141-37-73,4-Epoxy-6-methylcyclohexylmethyl-3,4-epoxy-6-methylcyclo-hexanecarboxylate311, Sup 7, 711999
141-90-2Thiouracil2BSup 7, 792001
142-83-62,4-Hexadienal2B1012013
143-50-0Chlordecone (Kepone)2B20, Sup 71987
143-67-9Vinblastine sulfate326, Sup 71987
144-34-3Methyl selenac312, Sup 71987
148-18-5Sodium diethyldithiocarbamate312, Sup 71987
148-24-38-Hydroxyquinoline313, Sup 71987
148-82-3Melphalan19, Sup 7, 100A2012
149-29-1Patulin340, Sup 71987
149-30-42-Mercaptobenzothiazole2A115In prep.
150-13-0para-Aminobenzoic acid316, Sup 71987
150-68-5Monuron3Sup 7, 531991
150-69-6Dulcin312, Sup 71987
151-56-4Aziridine2B9, Sup 7, 711999NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
154-93-8Bischloroethyl nitrosourea (BCNU)2A26, Sup 71987
156-10-5para-Nitrosodiphenylamine327, Sup 71987
156-51-4Phenelzine sulfate324, Sup 71987
189-55-9Dibenzo[a,i]pyrene2B922010
189-64-0Dibenzo[a,h]pyrene2BSup 7, 922010
191-07-1Coronene332, Sup 7, 921987
191-24-2Benzo[ghi]perylene392, Sup 72010
191-26-4Anthanthrene392, Sup 72010
191-30-0Dibenzo[a,l]pyrene2ASup 7, 922010NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
192-47-2Dibenzo[h,rst]pentaphene3Sup 7, 922010
192-51-8Dibenzo[e,l]pyrene3922010
192-65-4Dibenzo[a,e]pyrene3Sup 7, 922010
192-97-2Benzo[e]pyrene392, Sup 72010
193-09-9Naphtho[2,3-e]pyrene3922010
193-39-5Indeno[1,2,3-cd]pyrene2BSup 7, 922010
194-59-27H-Dibenzo[c,g]carbazole2B32, Sup 7, 1032013
195-19-7Benzo[c]phenanthrene2B92, Sup 72010NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
196-78-1Benzo[g]chrysene3922010
198-55-0Perylene3Sup 7, 922010
202-33-5Benz[j]aceanthrylene2B922010NB: Overall evaluation upgraded to Group 2B with supporting mechanistic and other relevant data
202-94-811H-Benz[bc]aceanthrylene3922010
202-98-24H-Cyclopenta[def]chrysene3922010
203-12-3Benzo[ghi]fluoranthene392, Sup 72010
203-20-3Naphtho[2,1-a]fluoranthene3922010
203-33-8Benzo[a]fluoranthene392, Sup 72010
205-12-9Benzo[c]fluorene392, Sup 72010
205-82-3Benzo[j]fluoranthene2B922010
205-99-2Benzo[b]fluoranthene2B922010
206-44-0Fluoranthene3Sup 7, 922010
207-08-9Benzo[k]fluoranthene2B922010
207-83-013H-Dibenzo[a,g]fluorene3922010
211-91-6Benz[l]aceanthrylene3922010
213-46-7Picene3922010
214-17-5Benzo[b]chrysene3922010
215-58-7Dibenz[a,c]anthracene3Sup 7, 922010
217-59-4Triphenylene3Sup 7, 922010
218-01-9Chrysene2B922010
224-41-9Dibenz[a,j]anthracene3Sup 7, 922010
224-42-0Dibenz[a,j]acridine2A32, Sup 7, 1032013NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
224-53-3Dibenz[c,h]acridine2B1032013NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
225-11-6Benz[a]acridine332, Sup 7, 1032013
225-51-4Benz[c]acridine332, Sup 7, 1032013
226-36-8Dibenz[a,h]acridine2B32, Sup 7, 1032013
238-84-6Benzo[a]fluorene392, Sup 72010
239-35-0Benzo[b]naphtho[2,1-d]thiophene31032013
243-17-4Benzo[b]fluorene392, Sup 72010
262-12-4Dibenzo-para-dioxin3691997
271-89-6Benzofuran2B631995
298-00-0Methyl parathion330, Sup 71987
298-81-7Methoxsalen (8-methoxypsoralen) plus ultraviolet A radiation124, Sup 7, 100A2012
299-75-2Treosulfan126, Sup 7, 100A2012
302-01-2Hydrazine2A4, Sup 7, 71, 115In prep.
302-17-0Chloral hydrate2A63, 84, 1062014
303-34-4Lasiocarpine2B10, Sup 71987
303-47-9Ochratoxin A2BSup 7, 561993
305-03-3Chlorambucil126, Sup 7, 100A2012
309-00-2Aldrin35, Sup 71987
313-67-7Aristolochic acid182, 100A2012NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
313-67-7Aristolochic acid, plants containing182, 100A2012
314-13-6Evans blue38, Sup 71987
315-18-4Zectran312, Sup 71987
315-22-0Monocrotaline2B10, Sup 71987
320-67-2Azacitidine2A501990NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
331-39-5Caffeic acid2B561993
333-41-5Diazinon2A1122015 onlineNB: Overall evaluation upgraded to Group 2A based on mechanistic evidence
334-88-3Diazomethane37, Sup 71987
335-67-1Perfluorooctanoic acid (PFOA)2B1102016 online
366-70-1Procarbazine hydrochloride2A26, Sup 71987NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
396-01-0Triamterene2B1082016
420-12-2Ethylene sulfide311, Sup 71987
439-14-5Diazepam3Sup 7, 661996
443-48-1Metronidazole2B13, Sup 71987
446-86-6Azathioprine126, Sup 7, 100A2012
480-54-6Retrorsine310, Sup 71987
480-81-9Seneciphylline310, Sup 71987
484-20-85-Methoxypsoralen2A40, Sup 71987NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
492-17-12,4'-Diphenyldiamine316, Sup 71987
492-80-8Auramine2B1, Sup 7, 99, 100F2012
493-52-7Methyl red38, Sup 71987
494-03-1Chlornaphazine14, Sup 7, 100A2012
494-03-1N,N-Bis(2-chloroethyl)-2-naphthylamine (see Chlornaphazine)
494-38-2Acridine orange316, Sup 71987
501-30-4Kojic acid3792001
505-60-2Mustard gas (see Sulfur mustard)
505-60-2Sulfur mustard19, Sup 7, 100F2012
509-14-8Tetranitromethane2B651996
510-15-6Chlorobenzilate330, Sup 71987
513-37-11-Chloro-2-methylpropene2B631995
518-75-2Citrinin340, Sup 71987
520-18-3Kaempferol331, Sup 71987
523-44-4CI Acid Orange 2038, Sup 71987
523-44-4Orange I (see CI Acid Orange 20)
523-50-2Angelicin plus ultraviolet A radiation340, Sup 71987
531-76-0Merphalan2B9, Sup 71987
531-82-8N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide2B7, Sup 71987
532-82-1Chrysoidine38, Sup 71987
536-33-4Ethionamide313, Sup 71987
540-73-81,2-Dimethylhydrazine2A4, Sup 7, 711999NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
541-73-1meta-Dichlorobenzene3731999
542-75-61,3-Dichloropropene (technical-grade)2B41, Sup 7, 711999
542-78-9Malonaldehyde336, Sup 7, 711999
542-88-1
107-30-2
Bis(chloromethyl)ether; chloromethyl methyl ether (technical-grade)14, Sup 7, 100F2012
545-06-2Trichloroacetonitrile352, 711999
545-55-1Tris(1-aziridinyl)phosphine oxide39, Sup 71987
551-74-6Mannomustine dihydrochloride39, Sup 71987
555-84-01-[(5-Nitrofurfurylidene)amino]-2-imidazolidinone2B7, Sup 71987
556-52-5Glycidol2A772000NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
562-10-7Doxylamine succinate3792001
563-41-7Semicarbazide hydrochloride312, Sup 71987
563-47-33-Chloro-2-methylpropene, technical grade2B63, 115In prep.
569-61-9CI Basic Red 92B57, 992010
581-89-52-Nitronaphthalene3461989
592-62-1Methylazoxymethanol acetate2B10, Sup 71987
593-60-2Vinyl bromide2A39, Sup 7, 71, 972008NB: (1) Overall evaluation upgraded to Group 2A based on mechanistic and other relevant data; (2) For practical purposes, vinyl bromide should be considered to act similarly to the human carcinogen vinyl chloride
593-70-4Chlorofluoromethane341, Sup 7, 711999
598-55-0Methyl carbamate312, Sup 71987
599-79-1Sulfasalazine2B1082016
602-60-89-Nitroanthracene333, Sup 71987
602-87-95-Nitroacenaphthene2B16, Sup 71987
604-75-1Oxazepam2BSup 7, 661996
606-20-22,6-Dinitrotoluene2B651996
607-57-82-Nitrofluorene2B46, 1052013
609-20-12,6-Dichloro-para-phenylenediamine339, Sup 71987
613-35-4N,N'-Diacetylbenzidine2B16, Sup 71987
615-05-42,4-Diaminoanisole2BSup 7, 792001
615-53-2N-Methyl-N-nitrosourethane2B4, Sup 71987
618-85-93,5-Dinitrotoluene3651996
621-64-7N-Nitrosodi-n-propylamine2B17, Sup 71987
627-12-3n-Propyl carbamate312, Sup 71987
630-20-61,1,1,2-Tetrachloroethane2B41, Sup 7, 71, 1062014
631-64-1Dibromoacetic acid2B1012013
632-99-5Magenta2BSup 7, 57, 99, 100F2012
637-07-0Clofibrate3Sup 7, 661996
641-48-5Dihydroaceanthrylene3922010
680-31-9Hexamethylphosphoramide2B15, Sup 7, 711999
684-93-5N-Methyl-N-nitrosourea2A17, Sup 71987NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
693-98-12-Methylimidazole2B1012013
712-68-52-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole2B7, Sup 71987
723-46-6Sulfamethoxazole3Sup 7, 792001
759-73-9N-Ethyl-N-nitrosourea2A17, Sup 71987NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
765-34-4Glycidaldehyde2B11, Sup 7, 711999
789-07-12-Nitropyrene3461989
794-93-4Dihydroxymethylfuratrizine (see also Panfuran S)324, Sup 71987
794-93-4Panfuran S (containing dihydroxymethylfuratrizine)2B24, Sup 71987
800-24-8Aziridyl benzoquinone39, Sup 71987
804-36-4Nitrovin331, Sup 71987
817-09-4Trichlormethine (Trimustine hydrochloride)2BSup 7, 501990
822-36-64-Methylimidazole2B1012013
828-00-2Dimethoxane315, Sup 71987
832-69-91-Methylphenanthrene3Sup 7, 922010
838-88-04,4'-Methylene bis(2-methylaniline)2B4, Sup 71987
842-07-9Sudan I38, Sup 71987
846-50-4Temazepam3661996
868-85-9Dimethyl hydrogen phosphite348, 711999
892-21-73-Nitrofluoranthene333, Sup 71987
915-67-3Amaranth38, Sup 71987
924-16-3N-Nitrosodi-n-butylamine2B17, Sup 71987
930-55-2N-Nitrosopyrrolidine2B17, Sup 71987
989-38-8Rhodamine 6G316, Sup 71987
1071-83-6Glyphosate2A1122015 online
1072-52-22-(1-Aziridinyl)ethanol39, Sup 71987
1116-54-7N-Nitrosodiethanolamine2B17, Sup 7, 772000
1120-71-41,3-Propane sultone2A4, Sup 7, 71, 110In prep.NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
1143-38-0Dithranol313; Sup 71987
1163-19-5Decabromodiphenyl oxide348, 711999
1303-00-0Gallium arsenide (see Arsenic and inorganic arsenic compounds)86, 100C2012
1309-37-1Ferric oxide31, Sup 71987
1309-64-4Antimony trioxide2B471989
1314-62-1Vanadium pentoxide2B862006
1317-60-8Haematite31, Sup 71987
1318-02-1Zeolites other than erionite (clinoptilolite, phillipsite,mordenite, non-fibrous Japanese zeolite, synthetic zeolites)3681997
1330-20-7Xylenes347, 711999
1332-21-4
77536-67-5*
12172-73-5
77536-66-4*
12001-29-5
12001-28-4
77536-68-6*
Asbestos (all forms, including actinolite, amosite, anthophyllite, chrysotile, crocidolite, tremolite)114, Sup 7, 100C2012NB: Mineral substances (e.g. talc or vermiculite) that contain asbestos should also be regarded as carcinogenic to humans<br/> *The presence of an asterisk indicates that the registration is for a substance which CAS does not treat in its regular CA index
1333-86-4Carbon black2BSup 7, 65, 932010
1336-36-3Polychlorinated biphenyls118, Sup 7, 1072016
1338-16-5Iron sorbitol-citric acid complex32, Sup 71987
1345-04-6Antimony trisulfide3471989
1401-55-4Tannic acid and tannins310, Sup 71987
1402-68-2Aflatoxins156, 82, 100F, Sup 72012
1464-53-51,2:3,4-Diepoxybutane (see Monographs on 1,3-Butadiene)11, Sup 71987
1582-09-8Trifluralin3531991
1615-80-11,2-Diethylhydrazine2B4, Sup 7, 711999
1634-04-4Methyl tert-butyl ether3731999
1675-54-3Bisphenol A diglycidyl ether (Araldite)347, 711999
1689-82-34-Hydroxyazobenzene38, Sup 71987
1694-09-3Benzyl violet 4B2B16, Sup 71987
1705-85-76-Methylchrysene3Sup 7, 922010
1706-01-03-Methylfluoranthene3Sup 7, 922010
1746-01-62,3,7,8-Tetrachlorodibenzo-para-dioxin1Sup 7, 69, 100F2012
1836-75-5Nitrofen (technical-grade)2B30, Sup 71987
1897-45-6Chlorothalonil2BSup 7, 731999
1912-24-9Atrazine353, 731999NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
1918-02-1Picloram3531991
1936-15-8CI Orange G38, Sup 71987
1936-15-8Orange G (see CI Orange G)
1937-37-7CI Direct Black 38 (see Benzidine, dyes metabolized to)
1954-28-5Triethylene glycol diglycidyl ether311, Sup 7, 711999
2068-78-2Vincristine sulfate326, Sup 71987
2164-17-2Fluometuron330, Sup 71987
2168-68-5Bis(1-aziridinyl)morpholinophosphine sulfide39, Sup 71987
2243-62-11,5-Naphthalenediamine327, Sup 71987
2303-16-4Diallate330, Sup 71987
2318-18-5Senkirkine331, Sup 71987
2353-45-9Fast Green FCF316, Sup 71987
2385-85-5Mirex2B20, Sup 71987
2386-90-5Bis(2,3-epoxycyclopentyl)ether 347, 711999
2425-06-1Captafol2A531991NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
2425-85-6CI Pigment Red 33571993
2429-74-5CI Direct Blue 152B571993
2432-99-711-Aminoundecanoic acid339, Sup 71987
2475-45-8Disperse Blue 12B481990
2602-46-2CI Direct Blue 6 (see Benzidine, dyes metabolized to)
2646-17-5Oil Orange SS2B8, Sup 71987
2757-90-6Agaritine331, Sup 71987
2783-94-0Sunset Yellow FCF38, Sup 71987
2784-94-3HC Blue No. 12B571993
2832-40-8Disperse Yellow 33481990
2835-39-4Allyl isovalerate336, Sup 7, 711999
2871-01-4HC Red No. 33571993
2955-38-6Prazepam3661996
2973-10-6Diisopropyl sulfate2B54, 711999
3018-12-0Dichloroacetonitrile352, 711999
3068-88-0beta-Butyrolactone2B11, Sup 7, 711999
3118-97-6Sudan II38, Sup 71987
3173-72-61,5-Naphthalene diisocyanate319, Sup 7, 711999
3252-43-5Dibromoacetonitrile2B52, 71, 1012013
3296-90-02,2-Bis(bromomethyl)propane-1,3-diol2B772000
3351-28-81-Methylchrysene3Sup 7, 922010
3351-30-24-Methylchrysene3Sup 7, 922010
3351-31-33-Methylchrysene3Sup 7, 922010
3351-32-42-Methylchrysene3Sup 7, 922010
3564-09-8Ponceau 3R2B8, Sup 71987
3567-69-9Carmoisine38, Sup 71987
3570-75-02-(2-Formylhydrazino)-4-(5-nitro-2-furyl)thiazole2B7, Sup 71987
3688-53-7AF-2 [2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide]2B31, Sup 71987
3697-24-35-Methylchrysene2BSup 7, 922010
3761-53-3Ponceau MX2B8, Sup 71987
3771-19-5Nafenopin2B24, Sup 71987
3778-73-2Isophosphamide326, Sup 71987
3795-88-85-(Morpholinomethyl)-3-[(5-nitrofurfurylidene)­amino]-2-oxazolidinone2B7, Sup 71987
3844-45-9Brilliant Blue FCF, disodium salt316, Sup 71987
3902-71-44,5',8-Trimethylpsoralen340, Sup 71987
4063-41-64,5'-Dimethylangelicin plus ultraviolet A radiation3Sup 71987
4170-30-3Crotonaldehyde3631995
4342-03-4Dacarbazine2B26, Sup 71987
4548-53-2Ponceau SX38, Sup 71987
4549-40-0N-Nitrosomethylvinylamine2B17, Sup 71987
4657-93-65-Aminoacenaphthene316, Sup 71987
4680-78-8Guinea Green B316, Sup 71987
5131-60-24-Chloro-meta-phenylenediamine327, Sup 71987
5141-20-8Light Green SF316, Sup 71987
5160-02-1D & C Red No. 93Sup 7, 571993
5307-14-21,4-Diamino-2-nitrobenzene3Sup 7, 571993
5385-75-1Dibenzo[a,e]fluoranthene3Sup 7, 922010
5431-33-4Glycidyl oleate311, Sup 71987
5456-28-0Ethyl selenac312, Sup 71987
5522-43-01-Nitropyrene2ASup 7, 46, 1052014NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
5589-96-8Bromochloroacetic acid2B1012013
5989-27-5d-Limonene356, 731999NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data
6164-98-3Chlordimeform330, Sup 71987
6358-53-8Citrus Red No. 22B8, Sup 71987
6368-72-5Sudan Red 7B38, Sup 71987
6373-74-6CI Acid Orange 33571993
6416-57-5Sudan Brown RR38, Sup 71987
6459-94-5CI Acid Red 1142B571993
6795-23-9Aflatoxin M12B561993
6870-67-3Jacobine310, Sup 71987
7099-43-65,6-Cyclopenteno-1,2-benzanthracene3922010
7220-79-3Methylene blue31082016
7439-92-1Lead2B23, Sup 71987
7439-97-6Mercury and inorganic mercury compounds3581993
7440-02-0Nickel, metallic and alloys2BSup 7, 491990
7440-07-5Plutonium178, 100D2012
7440-29-1Thorium-232 and its decay products178, 100D2012
7440-38-2Arsenic and inorganic arsenic compounds123, Sup 7, 100C2012
7440-41-7Beryllium and beryllium compounds1Sup 7, 58, 100C2012
7440-43-9Cadmium and cadmium compounds158, 100C2012
7440-47-3Chromium, metallic3Sup 7, 491990
7440-48-4Cobalt and cobalt compounds2B521991NB: Evaluated as a group
7440-48-4Cobalt metal without tungsten carbide2B862006
7440-48-4
12070-12-1
Cobalt metal with tungsten carbide2A862006
7446-09-5Sulfur dioxide3541992
7460-84-6Glycidyl stearate311, Sup 71987
7481-89-2Zalcitabine2B762000
7496-02-86-Nitrochrysene2ASup 7, 46, 1052014NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
7519-36-0N-Nitrosoproline317, Sup 71987
7572-29-4Dichloroacetylene339, Sup 7, 711999
7631-86-9Silica, amorphous3Sup 7, 681997
7647-01-0Hydrochloric acid3541992
7664-93-9Strong-inorganic-acid mists containing sulfuric acid (see Acid mists)
7722-84-1Hydrogen peroxide336, Sup 7, 711999
7758-01-2Potassium bromate2BSup 7, 731999
7758-19-2Sodium chlorite3521991
7782-49-2Selenium and selenium compounds39, Sup 71987
8001-35-2Toxaphene (Polychlorinated camphenes)2BSup 7, 792001
8001-50-1Terpene polychlorinates (Strobane®)35, Sup 71987
8001-58-9Creosotes2ASup 7, 922010
8002-05-9Crude oil3451989
8007-45-2Coal tars (see Coal-tar distillation)35, Sup 71987
8007-45-2Coal-tar distillation192, 100F2012
8018-07-3Acriflavinium chloride313, Sup 71987
8047-67-4Saccharated iron oxide32, Sup 71987
8052-42-4Bitumens, extracts of steam-refined and air-refined; steam-refined, cracking-residue and air-refined bitumens (see Bitumens, occupational exposures)35, Sup 71987
8052-42-4
64741-56-6
Bitumens, occupational exposure to straight-run bitumens and their emissions during road paving2B1032013
9000-07-1Carrageenan, native331, Sup 71987
9000-38-8Kava extract2B1082016
9002-84-0Polytetrafluoroethylene319, Sup 71987
9002-86-2Polyvinyl chloride319, Sup 71987
9002-88-4Polyethylene319, Sup 71987
9002-89-5Polyvinyl alcohol319, Sup 71987
9003-01-4Polyacrylic acid319, Sup 71987
9003-07-0Polypropylene319, Sup 71987
9003-20-7Polyvinyl acetate319, Sup 71987
9003-22-9Vinyl chloride-vinyl acetate copolymers319, Sup 71987
9003-39-8Polyvinyl pyrrolidone319, Sup 7, 711987
9003-53-6Polystyrene319, Sup 71987
9003-54-7Styrene-acrylonitrile copolymers319, Sup .71987
9003-55-8Styrene-butadiene copolymers319, Sup 71987
9004-51-7Iron-dextrin complex32, Sup 71987
9004-66-4Iron-dextran complex2B2, Sup 71987
9009-54-5Polyurethane foams319, Sup 71987
9010-98-4Polychloroprene319, Sup 71987
9011-06-7Vinylidene chloride-vinyl chloride copolymers319, Sup 71987
9011-14-7Polymethyl methacrylate319, Sup 71987
9016-87-9Polymethylene polyphenyl isocyanate319, Sup 71987
10026-24-1Cobalt sulfate and other soluble cobalt(II) salts2B862006
10043-66-0Iodine-131 (see Radioiodines)
10043-92-2Radon-222 and its decay products143, 78, 100D2012
10048-13-2Sterigmatocystin2B10, Sup 71987
10048-32-5Parasorbic acid310, Sup 71987
10098-97-2Strontium-90 (see Fission products)
10380-28-6Copper 8-hydroxyquinoline315, Sup 71987
10540-29-1Tamoxifen166, 100A2012NB: There is also conclusive evidence that tamoxifen reduces the risk of contralateral breast cancer in breast cancer patients
10595-95-6N-Nitrosomethylethylamine2B17, Sup 71987
10599-90-3Chloramine3842004
11056-06-7Bleomycins2B26, Sup 71987NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
12001-79-5Vitamin K substances3762000
12070-12-1
7440-48-4
Tungsten carbide with cobalt metal (see Cobalt metal with tungsten carbide)
12122-67-7Zineb312, Sup 71987
12174-11-7Attapulgite (see Palygorskite)
12174-11-7Palygorskite (Attapulgite) (long fibres, > 5 micrometres)2B681997
12174-11-7Palygorskite (Attapulgite)(short fibres, < 5 micrometres)3681997
12192-57-3Aurothioglucose313, Sup 71987
12427-38-2Maneb312, Sup 71987
12663-46-6Cyclochlorotine310, Sup 71987
13010-47-41-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)2A26, Sup 71987NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
13045-94-8Medphalan39, Sup 71987
13233-32-4Radium-224 and its decay products178, 100D2012
13256-22-9N-Nitrososarcosine2B17, Sup 71987
13292-46-1Rifampicin324, Sup 71987
13463-67-7Titanium dioxide2B47, 932010
13483-18-61,2-Bis(chloromethoxy)ethane315; Sup 7, 711999
13909-09-61-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (Methyl-CCNU) (see Semustine)
13909-09-6Semustine [1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea, Methyl-CCNU]1Sup 7, 100A2012
13982-63-3Radium-226 and its decay products178, 100D2012
13983-17-0Wollastonite3Sup 7, 681997
14484-64-1Ferbam312, Sup 71987
14596-37-3Phosphorus-32, as phosphate178, 100D2012
14807-96-6Talc containing asbestiform fibres (see Asbestos)42, Sup 71987
14807-96-6Talc not containing asbestos or asbestiform fibres342, Sup 7, 932010
14807-96-6Talc-based body powder (perineal use of)2B932010
14808-60-7Silica dust, crystalline, in the form of quartz or cristobalite1Sup 7, 68, 100C2012
14901-08-7Cycasin2B10, Sup 71987
15086-94-9Eosin315, Sup 71987
15262-20-1Radium-228 and its decay products178, 100D2012
15501-74-3Sepiolite3Sup 7, 681997
15503-86-3Isatidine310, Sup 71987
15663-27-1Cisplatin2A26, Sup 71987NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
15721-02-52,2',5,5'-Tetrachlorobenzidine327, Sup 71987
16065-83-1Chromium (III) compounds3491990
16071-86-6CI Direct Brown 95 (see Benzidine, dyes metabolized to)
16543-55-8
64091-91-4
N'-Nitrosonornicotine (NNN) and 4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK)1Sup 7, 89, 100E2012NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
16568-02-8Gyromitrin331, Sup 71987
16984-48-8Fluorides (inorganic, used in drinking-water)327, Sup 71987
17117-34-93-Nitrobenzanthrone2B1052014NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
18540-29-9Chromium (VI) compounds1Sup 7, 49, 100C2012
18883-66-4Streptozotocin2B17, Sup 71987
20073-24-93-Carbethoxypsoralen340, Sup 71987
20268-51-37-Nitrobenz[a]anthracene3461989
20589-63-33-Nitroperylene3461989
20830-75-5Digoxin2B1082016
20830-81-3Daunomycin2B10, Sup 71987
20941-65-5Ethyl tellurac312, Sup 71987
21884-44-6Luteoskyrin310, Sup 71987
22248-79-9Tetrachlorvinphos2B30, Sup 7, 112In prep.
22349-59-31,4-Dimethylphenanthrene3Sup 7, 922010
22398-80-7Indium phosphide2A862006NB: Overall evaluation upgraded to Group 2A
22506-53-23,9-Dinitrofluoranthene2B46, 65, 1052013
22571-95-5Symphytine331, Sup 71987
22966-79-6Oestradiol mustard39, Sup 71987
22975-76-44,4'-Dimethylangelicin plus ultraviolet A radiation3Sup 71987
23214-92-8Adriamycin2A10, Sup 71987NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
23246-96-0Riddelliine2B10, Sup 7, 822002
23255-93-8Hycanthone mesylate313, Sup 71987
23537-16-8Rugulosin340, Sup 71987
23746-34-1Potassium bis(2-hydroxyethyl)dithiocarbamate312, Sup 71987
24560-98-3cis-9,10-Epoxystearic acid311, Sup 7, 711999
24938-64-5para-Aramid fibrils3681997
25013-15-4Vinyl toluene3601994
25013-16-5Butylated hydroxyanisole (BHA)2B40, Sup 71987
25038-54-4Nylon 6319, Sup 71987
25732-74-5Acepyrene (3,4-dihydrocyclopenta[cd]pyrene)3922010
25812-30-0Gemfibrozil3661996
25962-77-0trans-2-[(Dimethylamino)methylimino]-5-[2-(5-nitro-2-furyl)-vinyl]-1,3,4-oxadiazole2B7, Sup 71987
26148-68-5A-alpha-C (2-Amino-9H-pyrido[2,3-b]indole)2B40, Sup 71987
26308-28-1Ripazepam3661996
26471-62-5Toluene diisocyanates2B39, Sup 7, 711999
26782-43-4Hydroxysenkirkine310, Sup 71987
27208-37-3Cyclopenta[cd]pyrene2ASup 7, 922010NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
28434-86-83,3'-Dichloro-4,4'-diaminodiphenyl ether2B16, Sup 71987
29069-24-7Prednimustine3501990
29291-35-8N-Nitrosofolic acid317, Sup 71987
29767-20-2Teniposide2A762000NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
29975-16-4Estazolam3661996
30310-80-6N-Nitrosohydroxyproline317, Sup 71987
30516-87-1Zidovudine (AZT)2B762000
33229-34-4HC Blue No. 23571993
33419-42-0Etoposide176, 100A2012NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
33419-42-0
15663-27-1
11056-06-7
Etoposide in combination with cisplatin and bleomycin176, 100A2012
33543-31-62-Methylfluoranthene3Sup 7, 922010
37319-17-8Pentosan polysulfate sodium2B1082016
37620-20-5N'-Nitrosoanabasine (NAB)337, Sup 7, 892007
38571-73-21,2,3-Tris(chloromethoxy)propane315, Sup 7, 711999
40762-15-0Doxefazepam3661996
42397-64-81,6-Dinitropyrene2B46, 1052013
42397-65-91,8-Dinitropyrene2BSup 7, 46, 1052013
51264-14-3Amsacrine2B762000
51481-61-9Cimetidine3501990
51630-58-1Fenvalerate3531991
52645-53-1Permethrin3531991
52918-63-5Deltamethrin3531991
53973-98-1Carrageenan, degraded (Poligeenan)2B31, Sup 71987
53973-98-1Poligeenan (see Carrageenan, degraded)
54749-90-5Chlorozotocin2A501990NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
55557-01-2N-Nitrosoguvacine3Sup 7, 852004
55557-02-3N-Nitrosoguvacoline3Sup 7, 852004
56894-91-81,4-Bis(chloromethoxymethyl)benzene315; Sup 7, 711999
57018-52-71-tert-Butoxypropan-2-ol3882006
57117-31-42,3,4,7,8-Pentachlorodibenzofuran1100F2012NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
57465-28-83,4,5,3’,4’-Pentachlorobiphenyl (PCB-126)1100F2012See Polychlorinated biphenyls, dioxin-like, with a TEF according to WHO
57835-92-44-Nitropyrene2B46, 1052013
59277-89-3Aciclovir3762000
59536-65-1Polybrominated biphenyls2A41, Sup 7, 1072016NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data, namely mechanistic similarity with polychlorinated biphenyls classified in Group 1
59820-43-8HC Yellow No. 43571993
59865-13-3
79217-60-0
Ciclosporin (see Cyclosporine)
59865-13-3
79217-60-0
Cyclosporine150, 100A2012
60102-37-6Petasitenine331, Sup 71987
60153-49-33-(N-Nitrosomethylamino)propionitrile2BSup 7, 852004
62450-06-0Trp-P-1 (3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole)2B31, Sup 71987
62450-07-1Trp-P-2 (3-Amino-1-methyl-5H-pyrido[4,3-b]indole)2B31, Sup 71987
63041-90-76-Nitrobenzo[a]pyrene3Sup 7, 461989
64436-13-1Arsenobetaine and other organic arsenic compounds that are not metabolized in humans3100C2012
64742-93-4Bitumens, occupational exposure to oxidized bitumens and their emissions during roofing2A1032013
65271-80-9Mitoxantrone2B762000
65996-93-2Coal-tar pitch135, Sup 7, 100F2012
66733-21-9Erionite142, Sup 7, 100C2012
67730-10-3Glu-P-2 (2-Aminodipyrido[1,2-a:3',2'-d]imidazole)2B40, Sup 71987
67730-11-4Glu-P-1 (2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole)2B40, Sup 71987
68006-83-7MeA-alpha-C (2-Amino-3-methyl-9H-pyrido[2,3-b]indole)2B40, Sup 71987
68308-34-9Shale oils135, Sup 7, 100F2012
68603-42-9Coconut oil diethanolamine condensate2B1012013
69655-05-6Didanosine3762000
71267-22-6N'-Nitrosoanatabine (NAT)337, Sup 7, 892007
73459-03-75-Methylangelicin plus ultraviolet A radiation3Sup 71987
75321-20-91,3-Dinitropyrene2B46, 1052013
76180-96-6IQ (2-Amino-3-methylimidazo[4,5-f]quinoline)2ASup 7, 561993NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
77094-11-2MeIQ (2-Amino-3,4-dimethylimidazo[4,5-f]quinoline)2BSup 7, 561993
77439-76-03-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone2B842004
77500-04-0MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline)2BSup 7, 561993
82413-20-5Droloxifene3661996
83463-62-1Bromochloroacetonitrile352, 711999
85502-23-43-(N-Nitrosomethylamino)propionaldehyde3Sup 7, 852004
85878-62-2Pyrido[3,4-c]psoralen340, Sup 71987
85878-63-37-Methylpyrido[3,4-c]psoralen340, Sup 71987
87625-62-5Ptaquiloside340, Sup 71987
89778-26-7Toremifene3661996
90045-36-6Ginkgo biloba extract2B1082016
90370-29-94,4',6-Trimethylangelicin plus ultraviolet A radiation3Sup 71987
90456-67-0 [deleted]
924-42-5
N-Methylolacrylamide3601994
101043-37-2Microcystin-LR2B942010
105650-23-5PhIP (2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine)2B561993
105735-71-53,7-Dinitrofluoranthene2B46, 65, 1052013
111025-46-8Pioglitazone2A1082016
111189-32-3Naphtho[1,2-b]fluoranthene3922010
116355-83-0Fumonisin B12B822002
116355-83-0Fusarium moniliforme, toxins derived from (fumonisin B1, fumonisin B2, and fusarin C)2B561993
118399-22-7Nodularins3942010
122320-73-4Rosiglitazone31082016
308068-56-6Carbon nanotubes, multi-walled MWCNT-72B111In prep.
308068-56-6Carbon nanotubes, multi-walled, other than MWCNT-73111In prep.
308068-56-6Carbon nanotubes, single-walled3111In prep.
308068-56-6Multi-walled carbon nanotubes MWCNT-7 (see Carbon nanotubes, multi-walled MWCNT-7)
308068-56-6Multi-walled carbon nanotubes other than MWCNT-7 (see Carbon nanotubes, multi-walled, other than MWCNT-7)
308068-56-6Single-walled carbon nanotubes (see Carbon nanotubes, single-walled)
308076-74-6Silicon carbide, fibrous2B111In prep.
409-21-2Silicon carbide whiskers2A111In prep.
Acheson process, occupational exposure associated with1111In prep.
Acid mists, strong inorganic154, 100F2012
Acrylic fibres319, Sup 71987
Acrylonitrile-butadiene-styrene copolymers319, Sup 71987
Alcoholic beverages144, 96, 100E2012
Aloe vera, whole leaf extract2B1082016
Alpha particles (see Radionuclides)
Aluminium production134, Sup 7, 92, 100F2012
Anaesthetics, volatile311, Sup 71987
Androgenic (anabolic) steroids2ASup 71987
Areca nut185, 100E2012
Art glass, glass containers and pressed ware (manufacture of)2A581993
Auramine production1Sup 7, 99, 100F2012
Benzidine, dyes metabolized to199, 100F2012NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data
Beta particles (see Radionuclides)
Betel quid with tobacco1Sup 7, 85, 100E2012
Betel quid without tobacco1Sup 7, 85, 100E2012
Biomass fuel (primarily wood), indoor emissions from household combustion of2A952010
Bisulfites3541992
Bitumens, occupational exposure to hard bitumens and their emissions during mastic asphalt work2B1032013
BK polyomavirus (BKV)2B1042013
Boot and shoe manufacture and repair (see Leather dust, Benzene)25, Sup 71987
Bracken fern2B40, Sup 71987
Calcium carbide production3922010
Carbon electrode manufacture2A922010
Carpentry and joinery2B25, Sup 71987
Ceramic implants3741999
Chimney sweeping (see Soot)922010
Chlorinated drinking-water3521991
Chlorinated paraffins of average carbon chain length C12 and average degree of chlorination approximately 60%2B481990
Chlorophenols (see Polychlorophenols)
Chlorophenoxy herbicides2B41, Sup 71987
Clonorchis sinensis (infection with)161, 100B2012
Coal dust3681997
Coal gasification1Sup 7, 92, 100F2012
Coal, indoor emissions from household combustion of195, 100E2012
Coffee (drinking)351, 116In prep.NB: There is <i>evidence suggesting lack of carcinogenicity</i> in humans of coffee drinking for cancers of the pancreas, liver, female breast, uterine endometrium, and prostate. Inverse associations with coffee drinking have been observed with cancers of the liver and uterine endometrium.
Coke production1Sup 7, 92, 100F2012
Continuous glass filament (see Glass filament)
Dental materials3741999
Diesel engine exhaust (see Engine exhaust, diesel)
Diesel fuel, marine2B451989NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
Diesel fuels, distillate (light)3451989
Dry cleaning (occupational exposures in)2B631995
Dyes metabolized to benzidine (see Benzidine, dyes metabolized to)
Electric fields, extremely low-frequency3802002
Electric fields, static3802002
Engine exhaust, diesel146, 1052013
Engine exhaust, gasoline2B46, 1052013
Epstein-Barr virus170, 100B2012
Estrogen therapy, postmenopausal172, 100A2012
Estrogen-progestogen menopausal therapy (combined)172, 91, 100A2012
Estrogen-progestogen oral contraceptives (combined)172, 91, 100A2012NB: There is also convincing evidence in humans that these agents confer a protective effect against cancer in the endometrium and ovary
Firefighter (occupational exposure as a)2B982010
Fission products, including strontium-901100D2012
Flat-glass and specialty glass (manufacture of)3581993
Fluorescent lighting3551992
Fluoro-edenite fibrous amphibole1111In prep.
Foreign  bodies (see Ceramic implants, Dental materials, Implanted foreign bodies, Metallic implants, Organic polymeric materials, Orthopaedic implants, Polymeric implants, Silicone breast implants)
2A952010
Fuel oils, distillate (light)3451989
Fuel oils, residual (heavy)2B451989
Furniture and cabinet making (see Wood dust)25, Sup 71987
Fusarium graminearum, F. culmorum, and F. crookwellense, toxins derived from (zearalenone, deoxynivalenol, nivalenol, and fusarenone X)3Sup 7, 561993
Fusarium sporotrichioides, toxins derived from (T-2 toxin)3561993
Gamma-Radiation (see X- and Gamma-Radiation)
Gasoline2B451989NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data
Gasoline engine exhaust (see Engine exhaust, gasoline)
Glass filament, continuous343, 812002
Goldenseal root powder2B1082016
Haematite mining (underground)11, Sup 7, 100D2012
Hair colouring products (personal use of)357, 992010
Hairdresser or barber (occupational exposure as a)2A57, 992010
Helicobacter pylori (infection with)161, 100B2012
Hepatitis B virus (chronic infection with)159, 100B2012
Hepatitis C virus (chronic infection with)159, 100B2012
Hepatitis D virus3591994
Hexachlorocyclohexanes2B20, Sup 71987
High-temperature frying (see Frying)
Household combustion of biomass fuel (see Biomass fuel, indoor emissions from household combustion of)
Household combustion of coal (see Coal, indoor emissions from household combustion)
Human herpesvirus type 4 (see Epstein-Barr virus)
Human herpesvirus type 8 (see Kaposi sarcoma herpesvirus)
Human immunodeficiency virus type 1 (infection with)167, 100B2012
Human immunodeficiency virus type 2 (infection with)2B671996
Human papillomavirus genus beta (except types 5 and 8) and genus gamma390, 100B2012
Human papillomavirus type 682A100B2012
Human papillomavirus types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59164, 90, 100B2012NB: The HPV types that have been classified as carcinogenic to humans can differ by an order of magnitude in risk for cervical cancer
Human papillomavirus types 26, 53, 66, 67, 70, 73, 822B100B2012
Human papillomavirus types 30, 34, 69, 85, 972B100B2012NB: Classified by phylogenetic analogy to the HPV genus alpha types classified in Group 1
Human papillomavirus types 5 and 8 (in patients with epidermodysplasia verruciformis)2B100B2012
Human papillomavirus types 6 and 11390, 100B2012
Human T-cell lymphotropic virus type I167, 100B2012
Human T-cell lymphotropic virus type II3671996
Hypochlorite salts3521991
Implanted foreign bodies of metallic chromium or titanium and of cobalt-based, chromium-based, and titanium-based alloys, stainless steel and depleted uranium 3741999
Implanted foreign bodies of metallic cobalt, metallic nickel and an alloy powder containing 66-67% nickel, 13-16% chromium, and 7% iron2B741999
Insulation glass wool343, 812002
Involuntary smoking (see Tobacco smoke, second-hand)
Ionizing radiation (all types)1100D2012
Iron and steel founding (occupational exposure during)134, Sup 7, 100F2012
Isopropyl alcohol manufacture using strong acids1Sup 7, 100F2012
Isopropyl oils315, Sup 7, 711999
JC polyomavirus (JCV)2B1042013
Jet fuel3451989
Kaposi sarcoma herpesvirus170, 100B2012
Lead compounds, inorganic2ASup 7, 872006
Lead compounds, organic323, Sup 7, 872006NB: Organic lead compounds are metabolized at least in part, to ionic lead both in humans and animals. To the extent that ionic lead, generated from organic lead, is present in the body, it will be expected to exert the toxicities associated with inorganic lead
Leather dust1100C2012
Leather goods manufacture325, Sup 71987
Leather tanning and processing325, Sup 71987
Lumber and sawmill industries (including logging)325, Sup 71987
Madder root (Rubia tinctorum)3822002
Magenta production1Sup 7, 57, 99, 100F2012
Magnetic fields, extremely low-frequency2B802002
Magnetic fields, static3802002
Malaria (caused by infection with Plasmodium falciparum in holoendemic areas)2A1042013
Mate, not very hot (drinking)351, 116In prep.
Mate, hot (see Very hot beverages)
Merkel cell polyomavirus (MCV)2A1042013
Metabisulfites3541992
Metallic implants prepared as thin smooth films2B741999
Methylmercury compounds2B581993NB: Evaluated as a group
Microcystis extracts3942010
Mineral oils, highly-refined333, Sup 71987
Mineral oils, untreated or mildly treated133, Sup 7, 100F2012
Modacrylic fibres319, Sup 71987
MOPP and other combined chemotherapy including alkylating agents1Sup 7, 100A2012
Neutron radiation175, 100D2012NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data
Nickel compounds1Sup 7, 49, 100C2012
Nickel refining (see Nickel compounds)111976
Nitrate or nitrite (ingested) under conditions that result in endogenous nitrosation2A942010
Non-arsenical insecticides (occupational exposures in spraying and application of)2A531991
Oestrogen (see Estrogen)
Opisthorchis felineus (infection with)3611994
Opisthorchis viverrini (infection with)161, 100B2012
Oral contraceptives, combined estrogen-progestogen (see Estrogen-progestogen oral contraceptives)
Organic polymeric materials3741999
Orthopaedic implants of complex composition and cardiac pacemakers3741999
Outdoor air pollution11092016
Outdoor air pollution, particulate matter in11092016
Paint manufacture (occupational exposure in)3471989
Painter (occupational exposure as a)147, 98, 100F2012
Particulate matter in outdoor air pollution (see Outdoor air pollution, particulate matter in)
Paving and roofing with coal-tar pitch (see Coal-tar pitch)35, Sup 7, 92, 100F2010
Petroleum refining (occupational exposures in)2A451989
Petroleum solvents3471989
Phenacetin, analgesic mixtures containing1Sup 7, 100A2012
Pickled vegetables (traditional Asian)2B561993
Polychlorinated biphenyls, dioxin-like, with a Toxicity Equivalency Factor (TEF) according to WHO (PCBs 77, 81, 105, 114, 118, 123, 126, 156, 157, 167, 169, 189)11072016NB: Overall evaluation upgraded to Group 1 with strong supporting evidence from other relevant data
Polychlorinated dibenzofurans (see 2,3,4,7,8-Pentachlorodibenzofuran)3691997
Polychlorinated dibenzo-para-dioxins (other than 2,3,7,8-tetrachlorodibenzo-para-dioxin)3691997
Polychlorophenols and their sodium salts (mixed exposures)2B53, 711999
Polymeric implant prepared as thin smooth films (with the exception of poly-glycolic acid)2B741999
Printing inks3651996
Printing processes (occupational exposures in)2B651996
Processed meat (consumption of)1114In prep.
Proflavine salts324, Sup 71987
Progestins2BSup 71987
Progestogen-only contraceptives2B721999
Pulp and paper manufacture325, Sup 71987
Radiofrequency electromagnetic fields2B1022013
Radioiodines, including iodine-131178, 100D2012
Radionuclides, alpha-particle-emitting, internally deposited178, 100D2012NB: Specific radionuclides for which there is sufficient evidence in humans are also listed individually as Group 1 agents
Radionuclides, beta-particle-emitting, internally deposited178, 100D2012NB: Specific radionuclides for which there is sufficient evidence in humans are also listed individually as Group 1 agents
Red meat (consumption of)2A114In prep.
Refractory ceramic fibres2B43, 812002
Rock (stone) wool343, 812002
Rubber manufacturing industry128, Sup 7, 100F2012
Salted fish, Chinese-style156, 100E2012
Schistosoma haematobium (infection with)161, 100B2012
Schistosoma japonicum (infection with)2B611994
Schistosoma mansoni (infection with)3611994
Shiftwork that involves circadian disruption2A982010
Silicone breast implants3741999
Slag wool343, 812002
Solar radiation155, 100D2012
Soot (as found in occupational exposure of chimney sweeps)135, Sup 7, 92, 100F2012
Special-purpose fibres such as E-glass and '475' glass fibres2B812002
Sulfites3541992
Sunlamps and sunbeds (see Ultraviolet-emitting tanning devices)
Surgical implants (see Ceramic implants, Dental materials, Implanted foreign bodies, Metallic implants, Organic polymeric materials, Orthopaedic implants, Polymeric implants, Silicone breast implants)
SV40 polyomavirus 31042013
Tea3511991
Tetrakis(hydroxymethyl)phosphonium salts348, 711999
Textile manufacturing industry (work in)2B481990
Tobacco smoke, second-hand183, 100E2012
Tobacco smoking183, 100E2012
Tobacco, smokeless1Sup 7, 89, 100E2012
Toxins derived from certain Fusarium species (see Fusarium)
Ultraviolet radiation (wavelengths 100-400 nm, encompassing UVA, UVB, and UVC)155, 100D2012
Ultraviolet-emitting tanning devices1100D2012
Urethane (see Ethyl carbamate)
Very hot beverages at above 65 °C (drinking)2A116In prep.
Welding fumes2B491990NB: Volume 100D concluded that there is sufficient evidence for ocular melanoma in welders
Wood dust162, 100C2012
Wood smoke (see Biomass fuel, indoor emissions from household combustion)
X- and Gamma-Radiation175, 100D2012
Last update 16 September 2016